GDF15 and coronary artery disorder: Unlike some other cardiovascular biomarkers, GDF15 plasma levels remain remarkably stable in CAD patients, both in the acute phase of coronary syndrome and in stable CAD, providing valuable short- to long-term prognostic information22.